Bringing Cancer Vaccines Closer to Patients: D2R Launches New Strategic Funding Initiative

Дата публикации: 03-08-2026 15:52:25

 
The DNA to RNA (D2R) Initiative is launching a new Strategic Initiative on Cancer Vaccines to accelerate the development of innovative cancer vaccine therapies and bring promising discoveries closer to patients.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	D2R awards $5.74 million in Translational Impact Research funding	0	13.51	29-04-2026
2	D2R launches major international projects to advance personalized genomic medicine	0	12.5	19-06-2026
3	D2R continues to invest in Canada's next generation of RNA research leaders	0	12.51	10-09-2026
4	McGill researchers driving the next phase of national cancer research network	0	6.57	08-10-2026
5	D2R x Lavery | Patenting Your Invention: A Guide for Researchers	0	4.3	15-04-2026
6	New Funding Opportunity: Ethical, Legal and Social Implications (ELSI) of Genomics Catalyst Grants	0	4.85	08-09-2026
7	EDI Workshop | EDI Missteps: Solutions, Strategies and Successful Practices	0	5.52	16-04-2026
8	GSK and LTZ announce strategic collaboration to advance novel myeloid cell engagers in oncology	0	7.12	19-11-2025
9	Expanding OxCITE: New funding to accelerate immunotherapy research	0	6.5	16-09-2026
10	В РАН предрекли прорыв в лечении рака персонализированными лекарствами	0	6.72	30-09-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5.71. Источник: www.mcgill.ca.